Website Disclaimer and Educational Mission
Psilobase.com is a harm reduction and educational resource. All information provided on this website is for educational purposes only and does not constitute medical, legal, or therapeutic advice. We do not encourage illegal activity. The information presented is intended to reduce risks for individuals who may encounter psilocybin-containing substances, consistent with the harm reduction framework established by organizations such as DanceSafe, MAPS (Multidisciplinary Association for Psychedelic Studies), and the Drug Policy Alliance.
Harm reduction communication is recognized as protected speech under the First Amendment in the United States and under analogous free expression provisions in most democratic nations. Providing accurate information about drug risks — without encouraging illegal use — has been upheld by courts as a legitimate public health function. Psilobase provides educational information in this spirit: our goal is to reduce preventable harm, not to facilitate any particular activity.
If you are facing a medical emergency, contact emergency services immediately. Always consult a licensed healthcare provider before making decisions about your health. The content on this site does not create a patient-provider relationship and should not be used as a substitute for professional medical or legal counsel.
Legal Status in the United States
In the United States, psilocybin and psilocin are classified as Schedule I controlled substances under the Controlled Substances Act of 1970. Schedule I designation means the federal government considers these substances to have "no currently accepted medical use and a high potential for abuse." This classification is increasingly contested by researchers, clinicians, and advocates: psilocybin has received FDA Breakthrough Therapy designation for treatment-resistant depression and major depressive disorder, a designation reserved for drugs showing substantial improvement over available treatments in early clinical evidence.
Federal scheduling means that manufacturing, distributing, dispensing, or possessing psilocybin is a federal crime regardless of state or local law. However, several jurisdictions have moved to reduce or eliminate penalties at the local level:
- Denver, Colorado became the first US city to decriminalize psilocybin in May 2019, making enforcement the lowest law-enforcement priority.
- Oakland, California passed a similar resolution weeks later in June 2019, extending decriminalization to all entheogenic plants and fungi.
- Washington, DC voters approved Initiative 81 in November 2020, making enforcement of psychedelic plant laws the city's lowest priority.
- Somerville, Cambridge, Easthampton, and Northampton, Massachusetts have passed similar resolutions decriminalizing personal use.
- Oregon voters passed Measure 109 in November 2020, creating a regulated therapeutic psilocybin service framework. Licensed psilocybin service centers began operating in 2023 under Oregon Health Authority supervision.
- Colorado voters approved Proposition 122 in 2022, establishing a regulated natural medicine program expected to begin licensed services in 2025.
These state and local actions do not override federal law. Federal prosecution for personal-quantity possession is rare, but the legal risk remains real.
International Legal Status Overview
The global legal picture for psilocybin is more varied than most people realize. Key jurisdictions include:
- Netherlands: Psilocybin mushrooms ("paddos") are illegal, but psilocybin truffles (sclerotia of species such as Psilocybe tampanensis) are not scheduled and are legally sold in smart shops. This legal gap has made the Netherlands a significant destination for psychedelic retreats, with facilitated sessions widely available.
- Jamaica: Psilocybin mushrooms are not scheduled under any national law, making cultivation, sale, and possession legal. Several licensed retreat centers operate openly and serve international clients.
- United Kingdom: Psilocybin is a Class A controlled substance — the most serious category — carrying potential penalties of up to 7 years imprisonment for possession and life imprisonment for supply. This is among the strictest classifications in Europe.
- Brazil: Psilocybin mushrooms are not explicitly scheduled, although general analogue provisions may apply. Their status occupies a legal grey area.
- Portugal: All personal drug use was decriminalized in 2001, meaning possession of small amounts is an administrative rather than criminal matter. Supply remains illegal.
- Canada: Psilocybin use is available in specific therapeutic contexts through Health Canada's Special Access Program, which allows licensed practitioners to apply for exemptions for individual patients with serious conditions.
- Austria: Psilocybin mushrooms are not explicitly listed as a controlled substance in Austrian law, creating a de facto grey area, though psilocybin itself remains scheduled.
Laws Change — Always Verify
The legal landscape for psilocybin is among the most rapidly evolving areas of drug policy globally. Legislative sessions, court rulings, ballot initiatives, and administrative rulemaking can change the status of psilocybin in a jurisdiction with little warning. The information on this page reflects our best understanding as of early 2026 and may be out of date by the time you read it.
Always consult current official legal resources and, where relevant, a qualified attorney before taking any action that might have legal consequences. Reliable resources for current information include MAPS (maps.org), the Drug Policy Alliance (drugpolicy.org), Erowid's law section (erowid.org/law), and Psychedelic Alpha's policy tracker (psychedelicalpha.com). For jurisdiction-specific legal questions, consult a licensed attorney with experience in drug law.
Psilobase assumes no liability for any legal consequences resulting from reliance on information published here. The legal information on this site is provided for educational context only and does not constitute legal advice.
Frequently Asked Legal Questions
Is psilocybin legal anywhere in the United States?
Psilocybin remains illegal under federal law throughout the United States. Oregon and Colorado have created regulated therapeutic frameworks at the state level. Several cities have decriminalized personal use, making enforcement the lowest law-enforcement priority. None of these state or local actions override federal Schedule I classification. Federal prosecutions for small personal quantities are rare but legally possible.
Can I be prosecuted under federal law even in a decriminalized city?
Yes. Federal law applies throughout the United States regardless of state or local policy. Decriminalization policies bind local law enforcement, not federal agencies. Federal prosecutions for small-quantity personal possession of psilocybin are historically rare — federal priorities typically focus on large-scale distribution — but the legal risk exists and should not be dismissed.
What does "harm reduction as protected speech" mean?
Courts have generally recognized that providing accurate information about drug risks — without encouraging illegal use — is protected by free expression principles. Organizations like DanceSafe have successfully defended this position in US courts. Psilobase provides educational information in this spirit. This is not legal advice, however, and specific communications involving facilitation of illegal activity may not receive the same protection.
Are psilocybin spores legal to possess?
In most US states, psilocybin spores do not contain psilocybin or psilocin and are therefore not covered by Schedule I classification. Spores are legally available in most states for microscopy and research purposes. However, California, Georgia, and Idaho specifically prohibit spore possession. Once spores are cultivated into mycelium or fruiting bodies containing psilocybin, they become Schedule I controlled substances in all US jurisdictions. Always verify current local law.
What is Oregon Measure 109?
Oregon Measure 109, passed by voters in November 2020, created a state-regulated framework allowing licensed facilitators to administer psilocybin in supervised therapeutic settings. Clients must be adults (21 and over); no prescription or clinical diagnosis is required. Psilocybin service centers began operating in 2023 following a two-year regulatory development period overseen by the Oregon Health Authority. The framework permits supervised use but not home possession or personal cultivation.
Is psilobase.com affiliated with any clinical or legal services?
No. Psilobase is an independent educational resource. We are not affiliated with clinics, legal services, retreat centers, or any commercial psilocybin-related businesses. We do not provide referrals to specific service providers. Our content is developed by researchers, harm reduction practitioners, and experienced writers with no commercial interest in any psychedelic service or product.
Can I travel internationally with psilocybin from a country where it is legal?
No. International transport of scheduled substances across national borders is governed by the 1971 UN Convention on Psychotropic Substances, which lists psilocine and psilocybine in Schedule I. Even traveling from Jamaica — where local law permits — to another country constitutes international drug trafficking under international law and the receiving country's import laws. Carry nothing across international borders.
Has the FDA approved psilocybin as a medicine?
As of early 2026, psilocybin has not received FDA approval as a prescription medicine. However, it has received FDA Breakthrough Therapy designation for treatment-resistant depression (2018) and major depressive disorder (2019). This designation expedites the regulatory review process and reflects preliminary clinical evidence of substantial benefit. Several Phase 2 and Phase 3 clinical trials are underway as of 2026.
What should I do if I am arrested for psilocybin-related charges?
Exercise your right to remain silent and immediately request legal representation. Do not discuss your case with law enforcement without an attorney present. Contact a criminal defense attorney with drug law experience. Organizations such as the National Organization for the Reform of Marijuana Laws (NORML) maintain directories of drug defense attorneys in the US. In other countries, contact a local criminal defense bar association for referrals.
Where can I find up-to-date legal information about psilocybin?
Reliable sources for current psilocybin legal information include: MAPS (maps.org) for US and international policy updates; the Drug Policy Alliance (drugpolicy.org) for US legislative tracking; Erowid's legal resources (erowid.org/law) for jurisdiction-by-jurisdiction status; and the Psychedelic Alpha policy tracker (psychedelicalpha.com) for global developments. For jurisdiction-specific questions with legal consequences, always consult a licensed attorney — online resources, including this one, can be out of date.